ACTO Appoints Former J&J President Lori Tierney to Board
ACTO Technologies, Inc. has announced the appointment of Lori Tierney to its Board of Directors, as stated in a press release. Tierney, who previously served as President of Johnson & Johnson Vision, brings over 20 years of experience in the life sciences industry.
Tierney's extensive background includes leadership roles at J&J MedTech, Mentor Aesthetics Specialty Surgery, AstraZeneca, Endo Pharmaceuticals, and Centocor. Her expertise in commercial operations and customer-centric innovation is expected to support ACTO's mission of pioneering an AI-first future in the life sciences sector.
ACTO's Intelligent Field Excellence platform aims to empower life sciences companies by providing AI-driven tools for field professionals, enhancing their engagement with healthcare providers. The platform also offers real-time insights for senior leaders to improve commercial execution.
Parth Khanna, CEO of ACTO, expressed enthusiasm about Tierney's appointment, highlighting her industry experience and vision as instrumental in advancing the company's AI initiatives.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Growth Acceleration Partners appoints Dwayne Stoltz as Vice President of AI
Cognetryx Names Julia Cherashore to Advisory Board
Andor Health Receives 2026 Frost & Sullivan Recognition for AI Care Orchestration
Assort Health and Nextech to Build AI Agent for Ophthalmology Practices
Xtalks Plans Webinar on AI Governance in Clinical Development
Daily AI Brief: the AI news that matters, in your inbox.